Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Sees Significant Decline in Short Interest

Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 50,500 shares, a decrease of 51.1% from the February 28th total of 103,300 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 609,700 shares, the days-to-cover ratio is currently 0.1 days.

Reckitt Benckiser Group Trading Down 1.0 %

Shares of OTCMKTS RBGLY traded down $0.13 during midday trading on Tuesday, reaching $13.45. 262,451 shares of the company traded hands, compared to its average volume of 333,361. The stock has a 50-day moving average price of $13.30 and a 200 day moving average price of $12.62. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. Reckitt Benckiser Group has a 52 week low of $10.24 and a 52 week high of $14.10.

Reckitt Benckiser Group Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 11th will be paid a $0.2909 dividend. This is a positive change from Reckitt Benckiser Group's previous dividend of $0.19. The ex-dividend date is Friday, April 11th.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Barclays lowered Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, February 4th. Royal Bank of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. HSBC raised shares of Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a report on Wednesday, December 11th. Finally, Hsbc Global Res raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, December 11th. Three research analysts have rated the stock with a hold rating, two have given a buy rating and three have issued a strong buy rating to the company. According to MarketBeat, Reckitt Benckiser Group currently has a consensus rating of "Buy".

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.